Patricia Hamminger, Luca Marchetti, Teresa Preglej, Renée Platzer, Ci Zhu, Anton Kamnev, Ramona Rica, Valentina Stolz, Lisa Sandner, Marlis Alteneder, Elisa Kaba, Darina Waltenberger, Johannes B. Huppa, Michael Trauner, Christoph Bock, Ruth Lyck, Jan Bauer, Loïc Dupré, Christian Seiser, Nicole Boucheron, Britta Engelhardt, Wilfried Ellmeier
7 min
Effector CD4+ T cells must migrate from lymphoid organs to inflamed tissues to coordinate immune responses, a process that can also drive autoimmune diseases. Previous research showed that T cell-specific deletion of the enzyme histone deacetylase 1 (HDAC1) protects mice from experimental autoimmune encephalomyelitis (EAE). This study investigates the underlying mechanism, specifically focusing on whether HDAC1 controls the trafficking of these autoreactive T cells.
The researchers utilized a combination of in vivo disease models, including EAE and adoptive T cell transfer colitis, to assess T cell function. They performed low-input RNA sequencing on antigen-specific CD4+ T cells to identify transcriptional changes following activation. To validate these findings, they employed in vitro transwell migration assays, high-content microscopy to analyze cell morphology on ICAM-1 surfaces, and live-cell imaging under physiological flow conditions to observe T cell interactions with brain endothelial cells.
HDAC1-deficient CD4+ T cells exhibit normal activation and expansion in vivo, ruling out defects in clonal proliferation as the cause of disease protection. Instead, transcriptome analysis revealed that HDAC1 is required for the expression of genes critical for leukocyte extravasation, such as the LFA-1 integrin subunits (CD11a and CD18) and various selectin ligands (CD43, CD44, and CD162).
Functional assays confirmed that HDAC1-deficient T cells have impaired adhesion to endothelial cells and reduced transendothelial migration capabilities. In the colitis model, these cells failed to home to the intestinal epithelium and lamina propria, which correlated with the observed downregulation of adhesion molecules. These results establish that HDAC1 acts as a central regulator of the T cell trafficking machinery required for tissue infiltration during autoimmunity.
This study provides a mechanistic explanation for the protective effect of HDAC1 deficiency in autoimmune models. By identifying HDAC1 as a key regulator of T cell migration, the findings highlight a potential therapeutic target for controlling T cell-mediated inflammation. It suggests that modulating HDAC1 activity could limit the recruitment of pathogenic T cells to target organs without necessarily impairing their initial activation or differentiation.
CD4+ T cell trafficking is a fundamental property of adaptive immunity. In this study, we uncover a novel role for histone deacetylase 1 (HDAC1) in controlling effector CD4+ T cell migration, thereby providing mechanistic insight into why a T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitis (EAE). HDAC1-deficient CD4+ T cells downregulated genes associated with leukocyte extravasation. In vitro, HDAC1-deficient CD4+ T cells displayed aberrant morphology and migration on surfaces coated with integrin LFA-1 ligand ICAM-1 and showed an impaired ability to arrest on and to migrate across a monolayer of primary mouse brain microvascular endothelial cells under physiological flow. Moreover, HDAC1 deficiency reduced homing of CD4+ T cells into the intestinal epithelium and lamina propria preventing weight-loss, crypt damage and intestinal inflammation in adoptive CD4+ T cell transfer colitis. This correlated with reduced expression levels of LFA-1 integrin chains CD11a and CD18 as well as of selectin ligands CD43, CD44 and CD162 on transferred circulating HDAC1-deficient CD4+ T cells. Our data reveal that HDAC1 controls T cell-mediated autoimmunity via the regulation of CD4+ T cell trafficking into the CNS and intestinal tissues.
Alex: [leaning back] Fascinating. You can find the full paper and the breakdown of these migration assays in the show notes. Thanks for walking me through that, Sam.
Sam: [warmly] Any time.
Alex: [curious, leaning in] So, if these cells are activated normally, they are essentially soldiers who have received their orders but are missing the equipment to actually storm the fortress?
Sam: [nodding, precise] Exactly. Without HDAC1, activated CD4+ T cells fail to upregulate the adhesion machinery required for extravasation. Specifically, they show reduced expression of LFA-1 integrin chains and selectin ligands like CD43. Without these, they cannot roll, arrest, or crawl on the endothelium to enter inflamed tissues.
Alex: [analytical, probing] So they are effectively blind to the signals that tell them where to go, even though they are fully primed?
Sam: [steady, teaching mode] That’s a fair frame. Think of the T cell at the blood-brain barrier. Normally, it receives signals to equip itself with climbing gear—the adhesion molecules. HDAC1 is the quartermaster. Without it, the soldier arrives at the wall without the gear. This explains why HDAC1-deficient mice are protected against EAE, despite having T cells perfectly capable of differentiating into inflammatory subsets.
Alex: [slower, processing] So the protection isn't because the T cells are incompetent, but because they are physically excluded from the site of disease?
Sam: [confirming, measured] Precisely. The authors showed that while HDAC1-deficient cells expand normally in lymph nodes, they fail to migrate when exposed to ICAM-1. This is the load-bearing finding: the decoupling of T cell activation from tissue pathology. It suggests that if we could target this trafficking program, we might block infiltration in conditions like multiple sclerosis without suppressing the entire systemic immune response.
Alex: [thoughtful] That is a significant distinction. But does the absence of HDAC1 affect homeostatic migration, or is this strictly limited to the inflammatory context?
Sam: [brief pause before speaking, direct] That is the critical question. The current data focuses on high-stress inflammatory models. Whether this gatekeeper function is essential for steady-state homing remains an open question. The authors provide a compelling mechanism for the inflammatory block, but the potential for off-target effects on non-pathogenic trafficking is the next hurdle.
Alex: [leaning back] Fascinating. You can find the full paper and the breakdown of these migration assays in the show notes. Thanks for walking me through that, Sam.
Sam: [warmly] Any time.
Alex: [analytical, leaning in] So, if these cells are activated normally, they are essentially soldiers who have received their orders but are missing the equipment to actually storm the fortress?
Sam: [nodding, precise] Exactly. Without HDAC1, activated CD4+ T cells fail to upregulate the adhesion machinery required for extravasation. Specifically, they show reduced expression of LFA-1 integrin chains and selectin ligands like CD43. Without these, they cannot roll, arrest, or crawl on the endothelium to enter inflamed tissues.
Alex: [analytical, probing] So they are effectively blind to the signals that tell them where to go, even though they are fully primed?
Sam: [steady, teaching mode] That’s a fair frame. Think of the T cell at the blood-brain barrier. Normally, it receives signals to equip itself with climbing gear—the adhesion molecules. HDAC1 is the quartermaster. Without it, the soldier arrives at the wall without the gear. This explains why HDAC1-deficient mice are protected against experimental autoimmune encephalomyelitis, despite having T cells perfectly capable of differentiating into inflammatory subsets.
Alex: [slower, processing] So the protection isn't because the T cells are incompetent, but because they are physically excluded from the site of disease?
Sam: [confirming, measured] Precisely. The authors showed that while HDAC1-deficient cells expand normally in lymph nodes, they fail to migrate when exposed to ICAM-1. This is the load-bearing finding: the decoupling of T cell activation from tissue pathology. It suggests that if we could target this trafficking program, we might block infiltration in conditions like multiple sclerosis without suppressing the entire systemic immune response.
Alex: [thoughtful] That is a significant distinction. But does the absence of HDAC1 affect homeostatic migration, or is this strictly limited to the inflammatory context?
Sam: [brief pause before speaking, direct] That is the critical question. The current data focuses on high-stress inflammatory models. Whether this gatekeeper function is essential for steady-state homing remains an open question. The authors provide a compelling mechanism for the inflammatory block, but the potential for off-target effects on non-pathogenic trafficking is the next hurdle.
Alex: [leaning back] Fascinating. If you want the figures and the method choices we skipped, you can generate a deep dive of this paper. The paper has the rest either way.
Sam: [warmly] Thanks for listening.